LifeSensors Inc. Receives $5.53 Million Funds from National Institutes of Health to Develop PROTAC Drug Discovery and Diagnosis of Alzheimer’s Disease Blog Post
LifeSensors is invited to speak at Discovery on Target 2023 – Breakthrough Molecules with Unique Molecular Glue & PROTAC Platform Blog Post
Accelerating PROTAC drug discovery: Establishing a relationship between ubiquitination and target protein degradation Blog Post
Accelerating PROTAC drug discovery: Establishing a Relationship Between Ubiquitination and Target Protein Degradation Blog Post
LifeSensors Invited to Speak at the Industry’s Preeminent 20th Annual Discovery on Target Conference Blog Post